Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-01-18FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, sub…
-
FDA approval · 2012-01-18FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker [Phase 4]
Phase 4 clinical trial comparing olmesartan/hydrochlorothiazide against an ACE inhibitor plus a calcium channel blocker for hypertension.
-
FDA label_change · 2012-01-18FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2012-01-17FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for atenolol from Aurobindo Pharma Limited, sanctioning a generic Atenolol product. This approva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Validation of WatchBP Office Ankle-brachial Index (ABI) Function
A completed clinical trial validated the WatchBP Office ankle-brachial index device for assessing ABI in patients with hypertension; results…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Nebivolol in Patients With Systolic Stage 2 Hypertension [Phase 4]
Phase 4 clinical trial update showing results for nebivolol in patients with systolic stage 2 hypertension; the study status is COMPLETED an…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Effects of Acute Ingestion of Dark Chocolate on Endothelial Function in Hypertensive Patients [Phase 4]
A Phase 4 trial evaluating the effects of acute dark chocolate ingestion on endothelial function in hypertensive patients has completed. The…
-
CLINICAL_TRIALS research · 2012-01-10Clinical Trial Update: An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension
This update reports the completion of an epidemiological study sponsored by AstraZeneca to evaluate standard daily practice in managing pati…
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions [Phase 1]
Phase 1 bioequivalence study of Dr. Reddy's amlodipine besylate/benazepril HCl 10 mg/40 mg capsules under fed conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions [Phase 1]
Phase 1 bioequivalence study of Dr. Reddy's amlodipine besylate/benazepril HCl 10 mg/40 mg capsules under fasting conditions has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women
A completed observational clinical trial from San Diego State University examined how socioeconomic status and psychosocial factors relate t…
-
CLINICAL_TRIALS trial_result · 2012-01-04Clinical Trial Update: A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension [Phase 3]
Phase 3 safety and tolerability study of azilsartan medoxomil in adults with essential hypertension has completed and results have been post…
-
CLINICAL_TRIALS research · 2012-01-04Clinical Trial Update: Web Based Interactive Treatment and Self-monitoring in Hypertension [NA]
This entry provides an update on a hypertension clinical trial evaluating a web-based interactive treatment and self-monitoring program, spo…
-
FDA approval · 2012-01-03FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for losartan potassium from Quallent Pharmaceuticals Health LLC for an existing generic product.
-
FDA approval · 2011-12-31FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amlodipine besylate from Aurobindo Pharma Limited, confirming continued approval of this generic…
-
FDA approval · 2011-12-31FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for amlodipine besylate from Teva Pharmaceuticals, Inc. Amlodipine besylate is used to treat hyp…
-
FDA approval · 2011-12-31FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Archis Pharma LLC)
The FDA approved a supplemental application for nicardipine hydrochloride from Archis Pharma LLC, approving the generic product under the AN…
-
FDA approval · 2011-12-31FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approves Solco Healthcare U.S., LLC's supplemental application for hydrochlorothiazide, enabling continued supply of the generic diureti…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
This update reports the results of a completed trial evaluating the added effect of a lifestyle program on antihypertensive treatment with t…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 [NA]
The clinical study evaluating a blood pressure monitor for conformance with ANSI/AAMI SP10 has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension [Phase 2]
Phase 2 trial evaluating aliskiren/amlodipine and amlodipine on ankle-foot volume in hypertension was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure [Phase 4]
Phase 4 clinical trial evaluating the role of COX-2 inhibition in salt sensitivity of blood pressure in hypertension; results have been post…
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Effect of Cocoa Consumption in Cardiovascular and Immune Parameters [NA]
The study examined the effect of cocoa consumption on cardiovascular and immune parameters in individuals with hypertension, but the trial s…
-
FDA approval · 2011-12-20FDA Approved: EDARBYCLOR — Original Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved EDARBYCLOR, a fixed-dose combination of azilsartan medoxomil and chlorthalidone, under an original NDA. The approval was grante…